Navigation Links


Haemostasis at Biology News

Haemostasis at Biology Products
Haemostasis at Biology Technology
Haemostasis at Medicine News
Haemostasis at Medicine Products
Haemostasis at Medicine Technology

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

RIDGEFIELD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 resultsfrom the RE-NOVATE(TM) trial demonstrated that oral dabigatranetexilate once daily, administered for an average of 33 days, wasnon-inferior to enoxaparin, also administered for an average of 33days, in preventing venous thromboembolism (VTE) and all-causemortality after total hip replacement surgery. In this trial, therate o...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies,Inc. (Nasdaq GM:NTEC) today announced that two poster presentationswere presented with its collaborative partner, Novo Nordisk A/S,relating to GlycoPEGylated recombinant Factor VIIa at the XXIstCongress of the International Society on Thrombosis and Haemostasisin Geneva, Switzerland. The data presented demonstrates thatGlycoPE...

Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

GENEVA, July 11, 2007 /PRNewswire/ -- InspirationBiopharmaceuticals today announced the presentation of preclinicaldata supporting the development of new, proprietary forms ofrecombinant Factor IX to treat patients with Hemophilia B. The datawere highlighted in an oral presentation and a poster session atthe XXIst Congress of the International Society on Thrombosis andHaemostasis (ISTH)...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- PortolaPharmaceuticals, Inc. announced positive Phase II data on its leadcompound, PRT054021, an oral Factor Xa inhibitor, today at the XXICongress of the International Society on Thrombosis and Haemostasis(ISTH) in Geneva, Switzerland. The EXPERT trial showed thatPRT054021 was safe, effective, and well tolerated for theprevention of venous th...

Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis

SAN CARLOS, Calif., July 5 /PRNewswire-FirstCall/ -- Nuvelo,Inc. (Nasdaq: NUVO) today announced that data from the ANTHEM(Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 Phase2 trial looking at recombinant nematode anticoagulant protein c2(rNAPc2) in patients with acute coronary syndromes (ACS),preclinical data evaluating rNAPc2 in mouse models of colorectalcancer, and precli...

More>>

Other TagsMALDILLCLLCZMDSpectrophotometerSpectrophotometerEnterpriseEnterprise
(Date:10/13/2008)...ontinuing Commitment by Financing All Cash Transa... Generation Enterprise ...ewswire-FirstCall/ -- Health,Systems Solutions, In...sdaq: EMAG ) today announced the signing of a def...tock of Emageon. The agreement was unanimously,app...
(Date:10/13/2008)... NSAID pain relievers, experts say , , ...killer Vioxx was pulled from the market in 2004 --... attack, stroke and death -- many assumed that sto... study finds that "the risk was increased close to... a year," said co-author Dr. Robert Bresalier, a p...
(Date:10/13/2008)...ng programs for inpatients that include follow-up ... improve patients, ability to stay smoke-free. An...t hospitals around the world finds that efforts fe...,s chances of success by 65 percent. The study l...arch and Treatment Center at Massachusetts General...
(Date:10/13/2008)...t the combination of low plasma levels of antioxid...iated with certain forms of the eye disease age-re...eport in the October issue of Archives of Ophthal..."The retina is vulnerable to the damaging effects ...tion in the article. "While wavelengths in the UV ...
Breaking Medicine News(10 mins):Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 2Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 3Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 4Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 5Health News:Health Systems Solutions Enters into Agreement to Acquire Emageon to Create Healthcare Technology Leader 6Health News:Vioxx's Heart Risk Lingered Long After Use Ended 2Health News:Vioxx's Heart Risk Lingered Long After Use Ended 3Health News:Intensive support programs can help hospitalized smokers stay smoke-free 2Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2
(Date:10/12/2008)...m neuronal synapses, astrocytes may finely tune sy...arning and memory, say Bergami et al. , The majo...term potentiation (LTP) and long-term depression (...municate with one another. Neurons that have under... the same level of a stimulus, whereas neurons tha...
(Date:10/12/2008)...al (October 12th) reveals how scientists from the ...using a novel nanomechanical approach to investiga...biotics that can be used to combat increasingly re...led by Dr Rachel McKendry and Professor Gabriel Ae...providing new insight into how antibiotics work, p...
(Date:10/10/2008)...e found that statins may be able to prevent miscar...omplications caused by antiphospholipid syndrome (...mune syndrome, the body produces antibodies direct...embranes. This news comes from a study published i...vestigation that is currently online in advance o...
(Date:10/10/2008)... and the Gladstone Institute of Cardiovascular Dis...oving the possibilities for the practical applicat...ogy. , Previously, Dr. Yamanaka had shown that a... stem celllike using a cancer-causing oncogene as ...lls, and a virus to transfer the genes into the ce...
Breaking Biology News(10 mins):Astrocytes and synaptic plasticity 2Nanotechnology boosts war on superbugs 2Statins may prevent miscarriages 2Statins may prevent miscarriages 3Yamanaka eliminates viral vector in stem cell reprogramming 2Traffic Fumes Plus Genes Boosts Kids Asthma Risk 140 1Traffic Fumes Plus Genes Boosts Kids Asthma Risk 140 2Actavis Receives Approval of Fentanyl Transdermal System in the U S 135 1Actavis Receives Approval of Fentanyl Transdermal System in the U S 135 260 second test could help early diagnosis of common brain diseases 124 160 second test could help early diagnosis of common brain diseases 124 2Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 1Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 2Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 3Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 4Systems Medicine 28SM 29 a Subsidiary of Cell Therapeutics Inc 28CTI 29 Announces Execution of CRADA with NCI NIH to Develop Potential Cancer Tr 132 5
Other Contentsabsorptionabsorptionabsorptionabsorptionabsorptionabsorptionabsorptionabsorptionacrosomeacrosomeactivationactivationactivationactivationactivationactivationactivationactivationactivationsitesitesitesitesitesitesitesitesitesiteactiveactiveactiveactiveactiveactiveactiveactiveactiveactiveradiationradiationradiationradiationradiationradiationradiationradiationradiationradiation